BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30296508)

  • 21. Tactile Stimulation in Adult Rats Modulates Dopaminergic Molecular Parameters in the Nucleus accumbens Preventing Amphetamine Relapse.
    Rossato DR; Rosa HZ; Rosa JLO; Milanesi LH; Metz VG; D'Àvila LF; Burger ME
    Mol Neurobiol; 2022 Sep; 59(9):5564-5573. PubMed ID: 35732868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats.
    Yu PL; Wu CI; Lee TS; Pan WH; Wang PS; Wang SW
    J Cell Biochem; 2009 Dec; 108(6):1318-24. PubMed ID: 19830701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-generational trans fat intake facilitates mania-like behavior: oxidative and molecular markers in brain cortex.
    Trevizol F; Roversi K; Dias VT; Roversi K; Barcelos RC; Kuhn FT; Pase CS; Golombieski R; Veit JC; Piccolo J; Pochmann D; Porciúncula LO; Emanuelli T; Rocha JB; Bürger ME
    Neuroscience; 2015 Feb; 286():353-63. PubMed ID: 25499313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parallel role for the dopamine D1 receptor in gambling and amphetamine reinforcement in healthy volunteers.
    Zack MH; Lobo DS; Biback C; Fang T; Smart K; Tatone D; Kalia A; Digiacomo D; Kennedy JL
    J Psychopharmacol; 2017 Jan; 31(1):31-42. PubMed ID: 27624149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of amphetamine exposure in relation to puberty onset determines its effects on anhedonia, exploratory behavior, and dopamine D
    Kang S; Wu MM; Galvez R; Gulley JM
    Neuroscience; 2016 Dec; 339():72-84. PubMed ID: 27702645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
    Velazquez-Sanchez C; Ferragud A; Renau-Piqueras J; Canales JJ
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):655-65. PubMed ID: 20735880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress-induced reinstatement of amphetamine-conditioned place preference and changes in tyrosine hydroxylase in the nucleus accumbens in adolescent rats.
    Cruz FC; Leão RM; Marin MT; Planeta CS
    Pharmacol Biochem Behav; 2010 Aug; 96(2):160-5. PubMed ID: 20460138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cAMP-dependent protein kinase and reward-related learning: intra-accumbens Rp-cAMPS blocks amphetamine-produced place conditioning in rats.
    Beninger RJ; Nakonechny PL; Savina I
    Psychopharmacology (Berl); 2003 Oct; 170(1):23-32. PubMed ID: 12768275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D1 receptor-mediated inhibition of medial prefrontal cortex neurons is disrupted in adult rats exposed to amphetamine in adolescence.
    Kang S; Paul K; Hankosky ER; Cox CL; Gulley JM
    Neuroscience; 2016 Jun; 324():40-9. PubMed ID: 26946269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
    Cancela LM; Basso AM; Martijena ID; Capriles NR; Molina VA
    Brain Res; 2001 Aug; 909(1-2):179-86. PubMed ID: 11478934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
    Berridge CW; Stalnaker TA
    Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
    Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
    Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild prenatal stress-modulated behavior and neuronal spine density without affecting amphetamine sensitization.
    Muhammad A; Kolb B
    Dev Neurosci; 2011; 33(2):85-98. PubMed ID: 21576912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Food restriction modulates amphetamine-conditioned place preference and nucleus accumbens dopamine release in the rat.
    Stuber GD; Evans SB; Higgins MS; Pu Y; Figlewicz DP
    Synapse; 2002 Nov; 46(2):83-90. PubMed ID: 12211086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA; Powers JP; Gulley JM
    Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-training, but not post-reactivation, administration of amphetamine and anisomycin modulates Pavlovian conditioned approach.
    Blaiss CA; Janak PH
    Neurobiol Learn Mem; 2007 May; 87(4):644-58. PubMed ID: 17258476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference of norepinephrine transporter trafficking motif attenuates amphetamine-induced locomotor hyperactivity and conditioned place preference.
    Mannangatti P; Ramamoorthy S; Jayanthi LD
    Neuropharmacology; 2018 Jan; 128():132-141. PubMed ID: 28986281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference.
    Islam F; Xu K; Beninger RJ
    Behav Brain Res; 2017 May; 326():217-225. PubMed ID: 28284949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The protein kinase Cβ-selective inhibitor, enzastaurin, attenuates amphetamine-stimulated locomotor activity and self-administration behaviors in rats.
    Altshuler RD; Carpenter CA; Franke TJ; Gnegy ME; Jutkiewicz EM
    Psychopharmacology (Berl); 2019 Nov; 236(11):3231-3242. PubMed ID: 31134292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.